Colorectal cancer (CRC) is the second leading cause of cancer death among men and women in the US. Due to this, early detection and prevention is crucial and decreases CRC mortality. American Cancer Society states multi-target stool DNA testing is a recommended method for colon cancer screening. The purpose of this study is to further increase the accuracy of this colon cancer screening technique.
We are currently seeking candidates for a paid clinical research study at Austin Regional Clinic Wilson Parke. This study is for adults who are 40 and older that have a colonoscopy scheduled in the next three to eight weeks. If you’d like to see if you qualify, please contact our research team. You can call our ARC Clinical Research team at 512-225-5931, or fill out our Clinical Research interest form online.